Impact of Body Mass Index on the Initial Phase of a Minimally Invasive Aortic Valve Program

Abstract

Background In obese patients, minimally invasive surgical aortic valve replacement (MIS-AVR) presents challenges, and the risk of patient–prosthesis mismatch (PPM) is elevated. This retrospective single-center study evaluates the impact of body mass index (BMI) on the outcome of an initial MIS-AVR program.

Material and Methods A total of 307 patients underwent MIS-AVR between January 2013 and December 2015, the initial phase of our MIS-AVR program. They were divided into normal/overweight (BMI <30 kg/m²) versus obese patients (BMI ≥30 kg/m²). Primary endpoints included 30-day and 2-year mortality and stroke. Secondary endpoints comprised type 3 bleeding, PPM, paravalvular leakage, wound healing disorders (WHDs), and pacemaker rates.

Results In all 191 patients exhibited a BMI <30 kg/m², while 116 patients had a BMI ≥30 kg/m². The BMI groups did not differ in baseline characteristics, excepting a higher peripheral arterial disease incidence among obese patients (15.7% vs. 26.7%; p = 0.01). Aortic clamp time (75 ± 29 min vs. 87 ± 37 min; p = 0.001), cardiopulmonary bypass (104 ± 36 min vs. 124 ± 56 min; p = 0.0002), and ventilation times (26 ± 6 h vs. 44 ± 8 h; p = 0.03) were longer in obese patients. They demonstrated a higher risk for bleeding (2.6% vs. 9.5%; p = 0.008) but lower pacemaker rates (9% vs. 3%; p = 0.02). PPM, paravalvular leakage, and WHD exhibited no group differences. No BMI-related differences revealed in 30-day mortality (4.7% vs. 3.4%) and stroke rates (2% vs. 2.6%), as well as 2-year mortality (12.6% vs. 11.2%) and stroke rates (2.1% vs. 2.6%).

Conclusion In the initial phase of an MIS-AVR program, the 30-day mortality may be elevated. Despite longer operative times and an increased risk for bleeding in obese patients, no influence of BMI on postoperative morbidity, mortality, or stroke rates was observed.

Keywords

minimally invasive surgery - heart valve surgery - aortic valve - obesity - outcome - wound healing

• References

• 1 Furukawa N, Kuss O, Aboud A. et al. Ministernotomy versus conventional sternotomy for aortic valve replacement: matched propensity score analysis of 808 patients. Eur J Cardiothorac Surg 2014; 46 (02) 221-226 , discussion 226–227
• 2 Merk DR, Lehmann S, Holzhey DM. et al. Minimal invasive aortic valve replacement surgery is associated with improved survival: a propensity-matched comparison. Eur J Cardiothorac Surg 2015; 47 (01) 11-17 , discussion 17
• 3 Isolated SAVR. . 2 2013–2022—partial vs. total sternotomy. GSTVS Annual Registry Survey Period 2013–2022. Accessed at: https://www.dgthg.de
• 4 Borger MA, Conradi L, Moustafine V. et al. Challenges and outcomes of minimally invasive aortic valve replacement: a comprehensive review. Ann Cardiothorac Surg 2015; 4 (02) 160-166
• 5 Young CP, Sinha S, Vohra HA. Outcomes of minimally invasive aortic valve replacement surgery. Eur J Cardiothorac Surg 2018; 53 (Suppl. 02) ii19-ii23
• 6 Hawkins RB, Mehaffey JH, Fonner CE. et al. The impact of obesity on outcomes following cardiac surgery. J Card Surg 2019; 34 (03) 182-188
• 7 Smith PJ, Wheeler MT, Lillie SE. Obesity and its implications for cardiac surgery. J Cardiothorac Vasc Anesth 2020; 34 (06) 1589-1596
• 8 Schlömicher M, Taghiyev Z, AlJabery Y. et al. Rapid deployment aortic valve replacement in a minimal access setting: intermediate clinical and echocardiographic outcomes. Eur J Cardiothorac Surg 2018; 54 (02) 354-360
• 9 Généreux P, Piazza N, Alu MC. et al; VARC-3 WRITING COMMITTEE. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol 2021; 77 (21) 2717-2746
• 10 Ghanta RK, LaPar DJ, Zhang Q. et al. Obesity increases risk-adjusted morbidity, mortality, and cost following cardiac surgery. J Am Heart Assoc 2017; 6 (03) e003831
• 11 Powell-Wiley TM, Poirier P, Burke LE. et al; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021; 143 (21) e984-e1010
• 12 Abdelaal SA, Abdelrahim NA, Mamdouh M. et al. Comparative effects of minimally invasive approaches vs. conventional for obese patients undergoing aortic valve replacement: a systematic review and network meta-analysis. BMC Cardiovasc Disord 2023; 23 (01) 392
• 13 Acharya M, Harling L, Moscarelli M, Ashrafian H, Athanasiou T, Casula R. Influence of body mass index on outcomes after minimal-access aortic valve replacement through a J-shaped partial upper sternotomy. J Cardiothorac Surg 2016; 11 (01) 74
• 14 Jensen MD, Ryan DH, Apovian CM. et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129 (25, Suppl 2): S102-S138
• 15 Florath I, Albert AA, Rosendahl UP. et al. Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement?. J Heart Valve Dis 2006; 15 (03) 336-344
• 16 Shehada SE, Elhmidi Y, Mourad F. et al. Minimal access versus conventional aortic valve replacement: a meta-analysis of propensity-matched studies. Interact Cardiovasc Thorac Surg 2017; 25 (04) 624-632
• 17 Agarwal S, Garg A, Parashar A. et al. In-hospital mortality and stroke after surgical aortic valve replacement: a nationwide perspective. J Thorac Cardiovasc Surg 2015; 150 (03) 571-8.e8
• 18 Thourani VH, Keeling WB, Kilgo PD. et al. The impact of body mass index on morbidity and short- and long-term mortality in cardiac valvular surgery. J Thorac Cardiovasc Surg 2011; 142 (05) 1052-1061
• 19 Costa VE, Ferolla SM, Reis TO. et al. Impact of body mass index on outcome in patients undergoing coronary artery bypass grafting and/or valve replacement surgery. Braz J Cardiovasc Surg 2015; 30 (03) 335-342
• 20 Salenger R, Gammie JS, Collins JA. Minimally invasive aortic valve replacement. J Card Surg 2016; 31 (01) 38-50
• 21 Schlömicher M, Bechtel M, Useini D. et al. Single-center outcomes with rapid deployment aortic valve replacement. Thorac Cardiovasc Surg 2021; 69 (05) 405-411
• 22 Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging 2016; 9 (08) 924-933
• 23 Forgie K, Bozso SJ, Hong Y. et al. The effects of body mass index on outcomes for patients undergoing surgical aortic valve replacement. BMC Cardiovasc Disord 2020; 20 (01) 255